Analyst Ratings for Diebold Nixdorf Inc. (DBD)Updated: 2017-07-27
Shares of Diebold Nixdorf Inc. (NYSE:DBD) have received a consensus rating of Overweight from Wall Street analysts. About 30 days ago, DBD was issued an average rating of Overweight.
Of the 9 analysts covering the stock, 6 gave it a buy rating, 0 gave an overweight rating, 3 issued a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.
Several price targets were given for DBD by the analysts covering the stock. The highest price target was 32, implying a possible profit of 38.83 percent. The most pessimistic price target was 26, implying a possible loss of 12.8 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.
Analysts have revised their earnings estimates downwards for this quarter, by about -75 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is -75 percent. Over the past 30 days, FY earnings estimates have also changed downwards by -37.68 percent. If we look at the last 90 days instead, we find a net average change of -37.87 percent in FY estimates.
Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 3 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 3 analysts decreased their estimates.
DBD has traded between a high of 31.85 and a low of 19.95 over the past year. Currently the stock is 15.54 percent higher than its low, and 27.63 percent lower than its 52-week high. DBD has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The DBD value stock report compares DBD to some of its peers using value stock charts. The stock has a market capitalization of $1.72 billion. DBD is estimated to release their earnings results for the quarter on 0000-00-00, days from today.